News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
525,154 Results
Type
Article (16944)
Company Profile (159)
Press Release (508043)
Multimedia
Podcasts (89)
Webinars (15)
Section
Business (181068)
Career Advice (798)
Deals (28582)
Drug Delivery (100)
Drug Development (59173)
Employer Resources (52)
FDA (10823)
Job Trends (9667)
News (260194)
Policy (20571)
Tag
2027 BioCapital Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (623)
Accelerated approval (33)
ADA (27)
Adcomms (22)
Allergies (113)
Alliances (36684)
ALS (128)
Alzheimer's disease (1223)
Antibody-drug conjugate (ADC) (361)
Approvals (11310)
Artificial intelligence (471)
ASCO (202)
Autoimmune disease (249)
Automation (35)
Bankruptcy (301)
Best Places to Work (7381)
BIO (53)
Biologics (1)
BIOSECURE Act (10)
Biosimilars (170)
BioSpace Insights (70)
Biotechnology (97)
Bladder cancer (165)
Brain cancer (36)
Breast cancer (566)
Cancer (4321)
Cardiovascular disease (341)
Career advice (659)
Career pathing (27)
CAR-T (213)
CDC (13)
Celiac Disease (1)
Cell therapy (587)
Cervical cancer (37)
Clinical research (52996)
Collaboration (1578)
Commercialization (5)
Company closure (2)
Compensation (1481)
Complete response letters (65)
COVID-19 (1063)
CRISPR (71)
C-suite (929)
Cystic fibrosis (91)
Data (6103)
Decentralized trials (1)
Denatured (17)
Depression (131)
Dermatology (76)
Diabetes (443)
Diagnostics (4442)
Digital health (45)
Diversity (8)
Diversity, equity & inclusion (13)
Drug discovery (241)
Drug pricing (171)
Drug shortages (26)
Duchenne muscular dystrophy (211)
Earnings (76675)
Editorial (47)
Employer branding (7)
Employer resources (58)
Events (92736)
Executive appointments (828)
FDA (13674)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (25)
Funding (1162)
Gene editing (153)
Generative AI (44)
Gene therapy (428)
GLP-1 (712)
Government (1645)
Grass and pollen (3)
Guidances (302)
Healthcare (10086)
Hematology (108)
HIV (69)
Huntington's disease (37)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (81)
Immunology and inflammation (247)
Immuno-oncology (86)
Indications (164)
Infectious disease (1320)
Inflammatory bowel disease (151)
Inflation Reduction Act (8)
Influenza (93)
Intellectual property (266)
Interviews (109)
IPO (13299)
IRA (42)
Job creations (2518)
Job search strategy (579)
JPM (41)
Kidney cancer (18)
Labor market (78)
Layoffs (279)
Leadership (31)
Legal (5814)
Licensing (10)
Liver cancer (57)
Longevity (18)
Lung cancer (605)
Lymphoma (314)
Machine learning (35)
Management (24)
Manufacturing (833)
Marketing (10)
MASH (159)
Medical device (8851)
Medtech (8995)
Mergers & acquisitions (16368)
Metabolic disorders (1207)
mRNA (109)
Multiple sclerosis (133)
NASH (12)
Neurodegenerative disease (320)
Neuropsychiatric disorders (79)
Neuroscience (2353)
Neurotech (1)
NextGen: Class of 2026 (3555)
Non-profit (945)
Now hiring (51)
Obesity (591)
Opinion (176)
Ovarian cancer (170)
Pain (214)
Pancreatic cancer (225)
Parkinson's disease (252)
Partnered (22)
Patents (550)
Patient recruitment (551)
Peanut (35)
People (45266)
Pharmaceutical (39)
Pharmacy benefit managers (28)
Phase 1 (16848)
Phase 2 (23732)
Phase 3 (16610)
Pipeline (7950)
Policy (208)
Postmarket research (1686)
Preclinical (6985)
Press Release (35)
Prostate cancer (219)
Psychedelics (31)
Radiopharmaceuticals (243)
Rare diseases (783)
Real estate (3624)
Recruiting (27)
Regulatory (16925)
Reports (32)
Research institute (742)
Resumes & cover letters (135)
Rett syndrome (41)
RNA editing (14)
RSV (73)
Schizophrenia (157)
Series A (198)
Series B (154)
Service/supplier (7)
Sickle cell disease (75)
Special edition (21)
Spinal muscular atrophy (108)
Sponsored (13)
Startups (2468)
Stomach cancer (12)
Supply chain (93)
Tariffs (93)
The Weekly (70)
Vaccines (489)
Venture capital (98)
Weight loss (390)
Women's health (93)
Worklife (8)
Date
Today (78)
Last 7 days (487)
Last 30 days (1841)
Last 365 days (21879)
2026 (13750)
2025 (21927)
2024 (25650)
2023 (29043)
2022 (37643)
2021 (39971)
2020 (36076)
2019 (26055)
2018 (19702)
2017 (21713)
2016 (20602)
2015 (26399)
2014 (23155)
2013 (19476)
2012 (21536)
2011 (21783)
2010 (21288)
Location
Africa (379)
Alabama (74)
Alaska (2)
Arizona (313)
Arkansas (12)
Asia (23616)
Australia (2725)
California (12239)
Canada (3274)
China (791)
Colorado (508)
Connecticut (448)
Delaware (244)
Europe (40570)
Florida (1873)
Georgia (377)
Hawaii (3)
Idaho (46)
Illinois (745)
India (82)
Indiana (362)
Iowa (16)
Japan (505)
Kansas (103)
Kentucky (31)
Louisiana (29)
Maine (26)
Maryland (1283)
Massachusetts (8225)
Michigan (316)
Minnesota (567)
Mississippi (5)
Missouri (83)
Montana (20)
Nebraska (14)
Nevada (116)
New Hampshire (62)
New Jersey (2851)
New Mexico (25)
New York (2956)
North Carolina (1364)
North Dakota (4)
Northern California (6107)
Ohio (321)
Oklahoma (15)
Oregon (20)
Pennsylvania (2320)
Puerto Rico (28)
Rhode Island (35)
South America (569)
South Carolina (76)
South Dakota (1)
Southern California (5066)
Tennessee (130)
Texas (1941)
United States (40378)
Utah (371)
Vermont (1)
Virginia (168)
Washington D.C. (51)
Washington State (957)
West Virginia (2)
Wisconsin (80)
Wyoming (1)
525,154 Results for "evoke pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evoke Pharma and QOL Medical Announce Expiration of Tender Offer
December 18, 2025
·
6 min read
Press Releases
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
November 5, 2025
·
10 min read
Press Releases
Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
November 14, 2025
·
12 min read
Press Releases
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study
June 9, 2026
·
19 min read
Press Releases
C2N Diagnostics Highlights First Use of Its eMTBR-tau243 Plasma Assay in Evoke/Evoke+ Phase 3 Dataset for Prediction of Cognitive and Functional Decline in Patients With Early Symptomatic Alzheimer’s Disease
March 19, 2026
·
3 min read
Press Releases
Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book
August 21, 2025
·
5 min read
China
As pharma descends on China for deals, BIOSECURE Act raises intellectual property risk
When signing a biotech licensing deal in China, experts say that pharma’s patent attorneys need to understand the geopolitical risk of the BIOSECURE Act.
July 28, 2026
·
7 min read
·
Annalee Armstrong
Press Releases
Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
August 15, 2025
·
10 min read
Business
Evoke Pharma Reports First Quarter 2024 Financial Results
Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced its financial results for the first quarter ended March 31, 2024, and recent corporate developments.
May 14, 2024
·
11 min read
Biotech Beach
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
Evoke Pharma, Inc., a specialty pharmaceutical company focused primarily on treatments for gastrointestinal diseases with an emphasis on GIMOTI® nasal spray, announced updates regarding their business and commercial growth strategy.
June 17, 2024
·
9 min read
1 of 52,516
Next
